LB Pharmaceuticals Inc

LBRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-8 Mar 26, 2026 S-8
10-K Mar 26, 2026 10-K
8-K Mar 26, 2026 8-K
8-K Mar 16, 2026 8-K
4 Mar 10, 2026
3 Mar 10, 2026
8-K Mar 10, 2026 8-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13D/A Feb 10, 2026
4 Feb 10, 2026 4
8-K Feb 5, 2026 8-K
SCHEDULE 13G Jan 21, 2026
SCHEDULE 13G/A Jan 21, 2026
SCHEDULE 13G Jan 21, 2026
SCHEDULE 13G Dec 31, 2025
4 Dec 11, 2025
3 Nov 18, 2025
8-K Nov 13, 2025 8-K
8-K Nov 12, 2025 8-K
10-Q Nov 6, 2025 10-Q
8-K Nov 6, 2025 8-K
SCHEDULE 13G Oct 17, 2025
4 Sep 29, 2025
3 Sep 29, 2025
SCHEDULE 13D Sep 25, 2025
← Newer Page 3 of 6 · 141 filings Older →